S. King

发表

In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase.

J. Montgomery, G. Gillespie, W. Waud, 1997, Human gene therapy.

Cell to Cell Contact Is Not Required for Bystander Cell Killing by Escherichia coli Purine Nucleoside Phosphorylase*

W. Parker, E. Sorscher, P. Allan, 1998, The Journal of Biological Chemistry.

NHE1 Inhibition by Amiloride- and Benzoylguanidine-type Compounds

S. Pedersen, E. B. Nygaard, P. Cala, 2007, Journal of Biological Chemistry.

R-domain interactions with distal regions of CFTR lead to phosphorylation and activation.

E. Sorscher, S. King, 2000, Biochemistry.

The Hdj‐2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis

D. Cyr, E. Sorscher, Zhen Lu, 1999, The EMBO journal.

Development of drug targeting based on recombinant expression of the chicken avidin gene.

Z. Bebők, M. Kulomaa, R. Reynolds, 1996, Journal of drug targeting.

Molecular cloning of NHE1 from winter flounder RBCs: activation by osmotic shrinkage, cAMP, and calyculin A.

S. Pedersen, P. Cala, R. Rigor, 2003, American journal of physiology. Cell physiology.

Regulation of the Pleuronectes americanus Na+/H+ exchanger by osmotic shrinkage, β-adrenergic stimuli, and inhibition of Ser/Thr protein phosphatases

S. Pedersen, P. Cala, S. King, 2006, Cell Biochemistry and Biophysics.

The Mechanism Underlying Cystic Fibrosis Transmembrane Conductance Regulator Transport from the Endoplasmic Reticulum to the Proteasome Includes Sec61β and a Cytosolic, Deglycosylated Intermediary*

Jeong S. Hong, E. Sorscher, Z. Bebök, 1998, The Journal of Biological Chemistry.

Recombinant synthesis of cystic fibrosis transmembrane conductance regulator and functional nucleotide-binding domains.

E. Sorscher, S. King, 1998, Methods in enzymology.

Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.

J. Clancy, S. Demolombe, D. Bedwell, 1998, Biochemistry.

Membrane transplantation to correct integral membrane protein defects

J. Clancy, D. Benos, E. Hunter, 2003, Journal of Molecular Medicine.

Efficiency of plasmid delivery and expression after lipid-mediated gene transfer to human cells in vitro.

A. Kraft, K. Kirk, W. Shaw, 1996, The Journal of pharmacology and experimental therapeutics.